Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
1(13%)
Results Posted
33%(2 trials)

Phase Distribution

Ph phase_3
1
13%
Ph not_applicable
1
13%
Ph phase_4
5
63%
Ph phase_2
1
13%

Phase Distribution

0

Early Stage

1

Mid Stage

6

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
1(12.5%)
Phase 4Post-market surveillance
5(62.5%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(6)
Other(1)

Detailed Status

Completed6
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (12.5%)
Phase 31 (12.5%)
Phase 45 (62.5%)
N/A1 (12.5%)

Trials by Status

unknown113%
completed675%
active_not_recruiting113%

Recent Activity

1 active trials
Showing 5 of 8
active_not_recruitingphase_2

Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension

NCT07168902
completedphase_4

Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects

NCT00735449
completedphase_4

Evaluation of Intraocular Pressure Using Simbrinza™ in Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT01978600
completedphase_4

24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients

NCT00330577
unknownphase_3

Effect of Topical Brimonidine on Post Cataract Surgery Corneal Edema

NCT00800423
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07168902Phase 2

Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension

Active Not Recruiting
NCT00735449Phase 4

Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects

Completed
NCT01978600Phase 4

Evaluation of Intraocular Pressure Using Simbrinza™ in Patients With Open-Angle Glaucoma or Ocular Hypertension

Completed
NCT00330577Phase 4

24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients

Completed
NCT00800423Phase 3

Effect of Topical Brimonidine on Post Cataract Surgery Corneal Edema

Unknown
NCT00273481Phase 4

Cosopt Versus Xalacom

Completed
NCT00435058Not Applicable

Visual Function Changes After Intraocular Pressure Reduction

Completed
NCT00273429Phase 4

Cosopt Versus Xalatan

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8